A consortium of previous and new venture capital and corporate investors has backed a $15m series-C for BC Platforms, a Switzerland-based genomic data management and analytics company.
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018